$6M Series AA Investment for Biotechnology Venture Fund

A biotechnology venture fund completed a $6 million Series AA investment in a privately held pharmaceutical company. Our firm represented the venture fund in the transaction.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.